Literature DB >> 20660611

Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice.

Julie A Musson1, Rebecca Ingram, Guillaume Durand, Stephanie Ascough, Emma L Waters, M Gillian Hartley, Timothy Robson, Bernard Maillere, E Diane Williamson, Shiranee Sriskandan, Daniel Altmann, John H Robinson.   

Abstract

Yersinia pestis is the causative agent of plague, a rapidly fatal infectious disease that has not been eradicated worldwide. The capsular Caf1 protein of Y. pestis is a protective antigen under development as a recombinant vaccine. However, little is known about the specificity of human T-cell responses for Caf1. We characterized CD4 T-cell epitopes of Caf1 in "humanized" HLA-DR1 transgenic mice lacking endogenous major histocompatibility complex class II molecules. Mice were immunized with Caf1 or each of a complete set of overlapping synthetic peptides, and CD4 T-cell immunity was measured with respect to proliferative and gamma interferon T-cell responses and recognition by a panel of T-cell hybridomas, as well as direct determination of binding affinities of Caf1 peptides to purified HLA-DR molecules. Although a number of DR1-restricted epitopes were identified following Caf1 immunization, the response was biased toward a single immunodominant epitope near the C terminus of Caf1. In addition, potential promiscuous epitopes, including the immunodominant epitope, were identified by their ability to bind multiple common HLA alleles, with implications for the generation of multivalent vaccines against plague for use in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660611      PMCID: PMC2950366          DOI: 10.1128/IAI.00195-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  HLA-DR restricted peptide candidates for bee venom immunotherapy.

Authors:  C Texier; S Pouvelle; M Busson; M Hervé; D Charron; A Ménez; B Maillère
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

2.  Differences between T cell epitopes recognized after immunization and after infection.

Authors:  Thorsten U Vogel; Helen Horton; Deborah H Fuller; Donald K Carter; Kathy Vielhuber; David H O'Connor; Tim Shipley; Jim Fuller; Gerd Sutter; Volker Erfle; Nancy Wilson; Louis J Picker; David I Watkins
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

3.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 4.  Second and third generation plague vaccines.

Authors:  Richard W Titball; E Diane Williamson
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

Review 5.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

Review 6.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  T V Inglesby; D T Dennis; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; J F Koerner; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; M Schoch-Spana; K Tonat
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

7.  Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis.

Authors:  Yidong Du; Roland Rosqvist; Ake Forsberg
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 8.  Vaccines against dangerous pathogens.

Authors:  E D Williamson; R W Titball
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

9.  Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.

Authors:  Stephen J Elvin; E Diane Williamson
Journal:  Microb Pathog       Date:  2004-10       Impact factor: 3.738

10.  Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli.

Authors:  H G Fischer; B Opel; K Reske; A B Reske-Kunz
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

View more
  9 in total

1.  CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.

Authors:  Julie A Musson; Catherine J Reynolds; Darawan Rinchai; Arnone Nithichanon; Prasong Khaenam; Emmanuel Favry; Natasha Spink; Karen K Y Chu; Anthony De Soyza; Gregory J Bancroft; Ganjana Lertmemongkolchai; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann; John H Robinson
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Authors:  Karen K Chu; Patcharaporn Tippayawat; Nicola J Walker; Sarah V Harding; Helen S Atkins; Bernard Maillere; Gregory J Bancroft; Ganjana Lertmemongkolchai; Daniel M Altmann
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

Review 3.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

4.  The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes.

Authors:  Jerome Kerzerho; Aurélie Schneider; Emmanuel Favry; Florence Anne Castelli; Bernard Maillère
Journal:  J Biol Chem       Date:  2013-04-03       Impact factor: 5.157

5.  The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.

Authors:  E D Williamson
Journal:  Adv Prev Med       Date:  2011-09-29

6.  Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine-Comparison of Immunoinformatic and Immunological Approaches.

Authors:  Valentina A Feodorova; Anna M Lyapina; Maria A Khizhnyakova; Sergey S Zaitsev; Yury V Saltykov; Vladimir L Motin
Journal:  Vaccines (Basel)       Date:  2020-11-19

7.  CD4+ T-Cell Epitope Prediction by Combined Analysis of Antigen Conformational Flexibility and Peptide-MHCII Binding Affinity.

Authors:  Tysheena Charles; Daniel L Moss; Pawan Bhat; Peyton W Moore; Nicholas A Kummer; Avik Bhattacharya; Samuel J Landry; Ramgopal R Mettu
Journal:  Biochemistry       Date:  2022-07-14       Impact factor: 3.321

8.  PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.

Authors:  Patricio Oyarzún; Jonathan J Ellis; Mikael Bodén; Boštjan Kobe
Journal:  BMC Bioinformatics       Date:  2013-02-14       Impact factor: 3.169

9.  The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.

Authors:  Catherine J Reynolds; Claire Jones; Christoph J Blohmke; Thomas C Darton; Amelie Goudet; Ruhena Sergeant; Bernard Maillere; Andrew J Pollard; Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.